EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Randomized clinical trial of duplex ultrasound surveillance after endovascular therapy for chronic limb-threatening ischemia

Marcos Roberto Godoy, Francisco Cardoso Brochado-Neto, Marcus Vinícius Martins Cury, Renato Manzioni, Ana Paula Maia Pires, Rodrigo Bruno Biagioni, Roberto Sacilotto, Marcelo Fernando Matielo

Journal of Vascular Surgery · 2025

DOI: 10.1016/j.jvs.2025.07.043 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Marcos Roberto Godoy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular and Endovascular Surgery, Institute of Medical Assistance to the State Public Servant, Sao Paulo, Brazil. Electronic address: …. Hauptthemen laut MEDLINE: Ultrasonography, Doppler, Duplex, Endovascular Procedures, Peripheral Arterial Disease, Ischemia. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to assess whether duplex ultrasound (DUS) surveillance yielded a better outcome compared with ankle-brachial index (ABI) surveillance after femoropopliteal endovascular therapy (EVT) in a cohort of patients affected by chronic limb-threatening ischemia (CLTI). METHODS: A single-center randomized controlled trial was conducted on consecutive admissions of patients with CLTI who underwent infra-inguinal EVT between March 2018 and January 2021. On the day after the operation, 203 patients were randomized to the ABI group (n = 103) or DUS group (n = 100) for follow-up at 1, 3, 6, 9, and 12 months, and every 6 months thereafter. The primary endpoint was femoropopliteal primary assisted patency (PAP), secondary patency (SP), and amputation-free survival (AFS) rates, and secondary endpoints included overall survival (OS) and freedom from reintervention (FFR) rates. Survival curves were presented as Kaplan-Meier plots. Log-rank tests were performed to compare the differences between the groups. RESULTS: After the early postprocedural period (≤30 days), 185 patients alive with a patent treated segment remained in the study (ABI group, n = 98; DUS group, n = 87). The average age was 72.3 years (55.7% female; 84.3% had hypertension; 81% had diabetes; and 88.6% had tissue loss). The overall mean follow-up period was 517 days (95% confidence interval, 440-574 days), with no statistical differences between the groups. Survival curves using the Kaplan-Meier method were reported considering a follow-up time of 540 days. There were no statistical differences in primary patency rate between the ABI group and the DUS group (56% vs 59%, respectively; P = .30). However, there was a statistical difference between the groups in PAP rate (67% vs 78%, respectively; P = .04) and SP rate (78% vs 86%, respectively; P = .02). There were no statistically significant differences between the groups in AFS rate (69% vs 82%, respectively; P = .07), OS rate (73% vs 83%, respectively; P = .20), and in FFR rate (66% vs 65%, respectively; P = 1.0). CONCLUSIONS: This single-center randomized controlled trial of patients with CLTI showed a significant benefit in terms of improved femoropopliteal PAP and SP rates in patients who underwent follow-up with DUS surveillance after infra-inguinal EVT; however, there was no difference in AFS, OS, and FFR rates between the groups. Our findings may contribute to the more comprehensive use of DUS surveillance after endovascular revascularization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultrasonography, Doppler, DuplexEndovascular ProceduresPeripheral Arterial DiseaseIschemiaFemoral ArteryPopliteal ArteryChronic Limb-Threatening IschemiaHumansMaleFemaleAgedVascular PatencyTime FactorsLimb SalvageMiddle AgedAmputation, SurgicalPredictive Value of TestsAnkle Brachial IndexAged, 80 and overTreatment OutcomeRisk FactorsChronic Disease

Stichwörter der Autor:innen

Ankle-brachial indexChronic limb-threatening ischemiaDuplex ultrasound surveillanceEndovascular therapyRandomized controlled trial

Autor:innen und Institutionen

  • Department of Vascular and Endovascular Surgery, Institute of Medical Assistance to the State Public Servant, Sao Paulo, Brazil. Electronic address: godoy.mrg@gmail.com.
  • Department of Vascular and Endovascular Surgery, Institute of Medical Assistance to the State Public Servant, Sao Paulo, Brazil.

Zitieren

APA

Godoy, M. R., Brochado-Neto, F. C., Martins Cury, M. V., Manzioni, R., Maia Pires, A. P., Biagioni, R. B., Sacilotto, R., & Matielo, M. F. (2025). Randomized clinical trial of duplex ultrasound surveillance after endovascular therapy for chronic limb-threatening ischemia. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.07.043

Vancouver

Godoy MR, Brochado-Neto FC, Martins Cury MV, Manzioni R, Maia Pires AP, Biagioni RB, et al. Randomized clinical trial of duplex ultrasound surveillance after endovascular therapy for chronic limb-threatening ischemia. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.07.043

BibTeX
@article{Godoy2025,
  author = {Godoy, Marcos Roberto and Brochado-Neto, Francisco Cardoso and Martins Cury, Marcus Vinícius and Manzioni, Renato and Maia Pires, Ana Paula and Biagioni, Rodrigo Bruno and Sacilotto, Roberto and Matielo, Marcelo Fernando},
  title = {Randomized clinical trial of duplex ultrasound surveillance after endovascular therapy for chronic limb-threatening ischemia},
  journal = {Journal of Vascular Surgery},
  year = {2025},
  doi = {10.1016/j.jvs.2025.07.043}
}
Kostenlos starten →